The 43rd meeting of the 5th Supervisory Board of Yan'an Bikon Pharmaceutical Co., Ltd. was held on May 11, 2023. The board unanimously approved a proposal to apply for pre-restructuring in court, affirming that the company's current situation meets the conditions set by the Enterprise Bankruptcy Law. The decision reflects the board's agreement on the necessity of this legal action for the company's financial restructuring.
Summary generated by AI · Always verify with source document
Yan'an Bikon Pharmaceutical Co., Ltd. and all members of the Supervisory Board guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.